Abbott Submits Humira sBLA for Juvenile Rheumatoid Arthritis

If approved, Humira would compete directly with Wyeth/Amgen’s Enbrel in the indication.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet